<< Back to News

System Formulary Update
Alzheimer's Treatments

Situation

The Alzheimer’s treatments class review and formulary standardization was approved at the January 2021 System Pharmacy and Therapeutics Committee meeting.

Background

The following medications were reviewed: donepezil, galantamine, memantine, rivastigmine

 Assessment/Recommendation

Changes effective: Tuesday March 9, 2021

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Donepezil tablet
• Memantine tablet
• Rivastigmine capsule and patch

Note: Stock of these formulary products may vary at individual entities

As a result, the following products will be removed from the UNC Health Medication Formulary:

• Donepezil ODT
• Memantine ER capsule and oral solution
• Donepezil and memantine combination capsule
• Galantamine tablet, capsule, and oral solution

Non-formulary orders will be converted according to a therapeutic interchange.